Apr
02
2009
The possibility of remote monitoring for chronically ill patients will soon become a reality. Now, researchers in South Africa and Australia have devised a decentralized system to avoid medical data overload. They describe the peer-to-peer system in a forthcoming issue of the International Journal of Computer Applications in Technology.
People with a range Continue Reading »
Apr
01
2009
The European Commission has granted marketing authorisation for Servier’s
Valdoxan(R) /Thymanax(R) (agomelatine), the first melatonergic antidepressant
for the treatment of adult patients with major depressive episodes.
devastating effects of depression," said Professor Goodwin from Warneford
Hospital, Oxford, United Kingdom. "Valdoxan is Continue Reading »
Mar
31
2009
Does stress damage the brain? In the March 1st issue of Biological Psychiatry, published by Elsevier, a paper by Tibor Hajszan and colleagues provides an important new chapter to this question.
This issue emerged in the 1990’s as an important clinical question with the observation by J. Douglas Bremner and colleagues, then at the VA National Center for Posttraumatic Stress Disorder (PTSD), that hippocampal volume was reduced Continue Reading »
Mar
30
2009
Identifying and treating depression, including increasing physical activity, may improve quality of life and reduce cardiovascular disease and death in African Americans, according to reports presented at the American Heart Association’s 2009 Conference on Nutrition, Physical Activity and Metabolism.
In one study, researchers in the Jackson Heart Study (JHS) found high depressive symptoms were prevalent Continue Reading »
Mar
26
2009
A new drug developed at the University of California, Davis to treat diabetes, hypertension and inflammatory has entered Phase II of human clinical trials to evaluate its efficacy.
Buy accutane The compound, a soluble epoxide hydrolase enzyme (s-EH) inhibitor, is "a first-in-class drug which may treat a suite Continue Reading »
Mar
13
2009
UI psychologist Kim Johnson and colleagues found in their research that when rats are deficient in sodium chloride, common table salt, they shy away from activities they normally enjoy, like drinking a sugary substance or pressing a bar that stimulates a pleasant sensation in their brains.
"Things that normally would be pleasurable for rats didn’t elicit the same degree of relish, which Continue Reading »
Mar
11
2009
Roche (SWX: RO, ROG;OTCQX: RHHBY) and Evotec (FSE: EVT; NASDAQ:EVTC) announced today that they have entered into an agreement for Phase II clinical development of EVT 101 in patients with treatment-resistant depression. The potential value of this transaction exceeds USD 300 million.
Evotec will be responsible for conducting Phase II studies for EVT 101, a compound originally discovered by Roche and developed from discovery Continue Reading »
Mar
11
2009
Certain men age 75 to 80 are unlikely to benefit from routine prostate specific antigen (PSA) testing, according to a Johns Hopkins study published in the April 2009 issue of The Journal of Urology.
The researchers found that men in this age group with PSA levels less than 3 nanograms per milliliter are unlikely to die of or experience aggressive prostate cancer during their remaining life, suggesting that Continue Reading »
Mar
09
2009
A new study in this week??s PLoS Medicine, reports that the risk of suicide increases two to three time on young men 24 years old or less who leave the UK Armed Forces than those remaining in active service or those in the general population.
In the first two years after discharge, the risk seems to increase in the men with short length of service, and those of inferior rank. Just 14 percent Continue Reading »
Mar
08
2009
Do you feel anxious before every dentist appointment? Do you find yourself feeling sick to your stomach or getting sweaty palms? Is getting your child into the dentist chair like pulling teeth?
Though dental anxiety is quite common, the Pennsylvania Dental Association (PDA) reminds the public that this fear can be easily managed, and is even preventable.
For children, Continue Reading »
Feb
18
2009
Many mistakenly believe recall involves national brands of peanut butter and are not aware of the range of products involved
A new national survey conducted by the Harvard Opinion Research Program at the Harvard School of Public Health finds that the vast majority (93%) of Americans have heard or read about the recent ongoing recall of peanut products. Among those who are Continue Reading »
Feb
15
2009
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) (the "Company" or "Ligand") announced positive preliminary results from the Phase IIb study for PS433540, the first-in-class Dual Acting Receptor Agonist (DARA) that targets the angiotensin and endothelin receptors.
The 261-patient, randomized, double-blind, placebo- and active-controlled study evaluated Continue Reading »
Feb
14
2009
VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced it has initiated a second pivotal Phase 3 study of avanafil, its investigational new drug for the treatment of erectile dysfunction (ED). Avanafil is a next-generation, fast-acting, Continue Reading »
Feb
14
2009
"Factors Associated With Self-Reported Depression in Arab-, Chaldean-, and African-Americans" (.pdf), Ethnicity & Disease: Researchers led by Hikmet Jamil of Wayne State University and colleagues surveyed 3,543 adults of Arab, Chaldean and African backgrounds living in Detroit, seeking to determine ethnicity-specific Continue Reading »
Feb
11
2009
Scientists in the United States say they have discovered a link between heart disease and erectile dysfunction - they say in some cases that risk is doubled.
The researchers at the Mayo Clinic in Minnesota say they have found that men who experience erectile dysfunction between the ages of 40 and 49 are twice as likely to develop heart disease than men without the problem.
According to a new study the highest Continue Reading »
Feb
09
2009
A thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden, concludes that people who have nightmares following a suicide attempt are five times more likely to attempt suicide again, compared with those who do not have nightmares.
The study included 165 patients aged 18-69 years, who were being treated at somatic and psychiatric departments following a suicide attempt Continue Reading »
Feb
07
2009
A family sociologist at the University at Buffalo says this month’s murder-suicides involving a family of four in Ohio and a family of five in California may be "just the tip of the iceberg."
Sampson Blair, Ph.D., associate professor of sociology at UB, says, "Family murder-suicide is still relatively uncommon, but I expect an increase Continue Reading »
Feb
05
2009
The September 11 terrorist attacks had a profound impact on this country’s psyche. Eight years after the attacks, we are still learning how those terrible events affected us. A number of studies have shown that people who lived closest to the sites of the terrorist attacks experienced heightened levels of stress and anxiety in the months following the September Continue Reading »
Feb
03
2009
The National Breast Cancer Coalition Fund has awarded 20 Advocacy in Action grants totaling $100,000 to member organizations selected by a competitive application process to assist groups in forwarding advocacy locally.
"These grants offer our member organizations support as they work to advance our goal of eradicating breast cancer," said Fran Visco, president of NBCCF. "The public Continue Reading »
Feb
01
2009
generic zithromax online buy A study released by researchers at the Columbia Center for Children’s Environmental Health (CCCEH) at Columbia University’s Mailman School of Public Health shows that developing antibodies to cockroach and mouse proteins is associated with a greater risk for wheeze, hay fever, and eczema in preschool urban children as young as three years of age. Continue Reading »
Jan
31
2009
A comprehensive meta-analysis of 12 new-generation antidepressants has shown sertraline and escitalopram have clear advantages in terms of efficacy and acceptability, while reboxetine was shown to be the significantly less efficacious than the Continue Reading »
Jan
31
2009
The world’s leading researchers in allergic disease will meet in Washington, DC, March 13-17, 2009, for the American Academy of Allergy, Asthma & Immunology’s (AAAAI) 2009 Annual Meeting. The AAAAI Annual Meeting is the largest U.S. gathering of allergist/immunologists, allied health professionals and researchers from around the world.
Medical, Consumer and Government Reporters will want to attend for these highlights:
- AAAAI Continue Reading »
Jan
29
2009
A new neuroimaging study on stressed-out students suggests that male humans, like male rats, don’t do their most agile thinking under stress. The findings, published this month in the Proceedings of the National Academy of Sciences, show that 20 male M.D. candidates in the middle of preparing for their board exams had a harder time shifting their attention from one task to another than other healthy young men who were not under the gun.
Previous experiments had Continue Reading »
Jan
28
2009
A study conducted by Universit?© de Montr?©al researchers on downstream and upstream water from the Montreal wastewater treatment plant has revealed the presence of chemotherapy products and certain hypertension and cholesterol medications.
Bezafibrate (cholesterol reducing medication), enalapril (hypertension medication), methotrexate and cyclophosphamide (two Continue Reading »
Jan
27
2009
Two studies presented today at the 8th International Forum on Mood and Anxiety Disorders (IFMAD) in Vienna demonstrated that once-daily SEROQUEL XRTM (quetiapine fumarate extended release tablets) provided significant symptom relief for elderly patients (>65 years of age) with major depressive disorder Continue Reading »